#read

Leipzig moves to the forefront of biotech research with centre for regenerative medicine

With the "CREATION - Centre for Gene- and Cell-Therapy in Regeneration and Transplantation" project, Leipzig, Hanover and Göttingen have made it onto the federal government's shortlist for outstanding research infrastructures. The aim is to establish a national centre that more closely interlinks research, clinical application and industrial translation of cell and gene therapies.

19/09/2025

The focus is on novel approaches such as standardised off-the-shelf therapies that do not have to be produced individually for each patient. At the same time, AI-supported processes should speed up the production of cell and gene therapeutics and reduce costs.

Leipzig is contributing its particular strengths in GMP production and clinical development to the consortium. The Fraunhofer IZI has already released over 4000 cell products for clinical trials and is one of the leading European institutions for the translation of immunotherapies. Together with Leipzig University Medicine and other partners, this could create a structure that ensures international competitiveness and at the same time strengthens the biotech cluster in Saxony.

The Federal Ministry of Research will decide on the final funding in November. If the bid is successful, over 80 million euros will be invested in construction and equipment by 2029, with a further 100 million euros earmarked for operations by 2038. This makes CREATION one of the largest biomedical infrastructure projects currently planned in Germany.

Article from "GoingPublic Media AG" dated 19 September 2025

The above texts, or parts thereof, were automatically translated from the original language text using a translation system (DeepL API).
Despite careful machine processing, translation errors cannot be ruled out.

Click here to access the original content